Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-020997

Chief Scientific Officer sold 2,899 shares at an average $0.61 ($1,779)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Loose Christopher R. Chief Scientific Officer 2023-07-17 Sale 10b5-1 −1,415 $0.67 $948 196,037 D: show line 1 in the form
Loose Christopher R. Chief Scientific Officer 2023-07-18 Sale 10b5-1 −1,484 $0.56 $831 194,553 D: show line 2 in the form
Open-market sales · 2,899 sh · avg $0.61 · $1,779
Loading xslF345X05/form4.xml…